PMID- 12200694 OWN - NLM STAT- MEDLINE DCOM- 20020926 LR - 20130304 IS - 0887-6924 (Print) IS - 0887-6924 (Linking) VI - 16 IP - 9 DP - 2002 Sep TI - Stromal cells from murine embryonic aorta-gonad-mesonephros region, liver and gut mesentery expand human umbilical cord blood-derived CAFC(week6) in extended long-term cultures. PG - 1782-90 AB - The first definitive long-term repopulating hematopoietic stem cells (HSCs) emerge from and undergo rapid expansion in the embryonic aorta-gonad-mesonephros (AGM) region. To investigate the presumptive unique characteristics of the embryonic hematopoietic microenvironment and its surrounding tissues, we have generated stromal clones from subdissected day 10 and day 11 AGMs, embryonic livers (ELs) and gut mesentery. We here examine the ability of 19 of these clones to sustain extended long-term cultures (LTCs) of human CD34(+) umbilical cord blood (UCB) cells in vitro. The presence of in vitro repopulating cells was assessed by sustained production of progenitor cells (extended LTC-CFC) and cobblestone area-forming cells (CAFC). The embryonic stromal clones differed greatly in their support for human HSCs. Out of eight clones tested in the absence of exogenous cytokines, only one (EL-derived) clone was able to provide maintenance of HSCs. Addition of either Tpo or Flt3-L + Tpo improved the long-term support of about 50% of the tested clones. Cultures on four out of 19 clones, ie the EL-derived clone mentioned, two urogenital-ridge (UG)-derived clones and one gastrointestinal (GI)-derived clone, allowed a continuous expansion of primitive CAFC and CFU-GM with over several hundred-fold more CAFC(week6) produced in the 12th week of culture. This expansion was considerably higher than that found with the FBMD-1 cell line, which is appreciated by many investigators for its support of human HSCs, under comparable conditions. This stromal cell panel derived from the embryonic regions may be a powerful tool in dissecting the factors mediating stromal support for maintenance and expansion of HSCs. FAU - Kusadasi, N AU - Kusadasi N AD - Institute of Hematology, Erasmus Medical Center Rotterdam, The Netherlands. FAU - Oostendorp, R A J AU - Oostendorp RA FAU - Koevoet, W J L M AU - Koevoet WJ FAU - Dzierzak, E A AU - Dzierzak EA FAU - Ploemacher, R E AU - Ploemacher RE LA - eng GR - R01 DK51077/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - England TA - Leukemia JT - Leukemia JID - 8704895 RN - 0 (Antigens, CD34) RN - 0 (Cytokines) SB - IM MH - Animals MH - Antigens, CD34/metabolism MH - Aorta/embryology MH - Cell Lineage MH - Cell Separation MH - Clone Cells/cytology MH - Coculture Techniques MH - Colony-Forming Units Assay MH - Cytokines/metabolism MH - Digestive System/embryology MH - Embryo, Mammalian/*cytology MH - Fetal Blood/*cytology MH - Gonads/embryology MH - Graft Survival MH - Hematopoiesis MH - Humans MH - Liver/embryology MH - Mesentery/embryology MH - Mesonephros/embryology MH - Mice MH - Mice, Transgenic MH - Reverse Transcriptase Polymerase Chain Reaction MH - Stem Cells/chemistry/*cytology/drug effects MH - Stromal Cells/*cytology/metabolism EDAT- 2002/08/30 10:00 MHDA- 2002/09/27 06:00 CRDT- 2002/08/30 10:00 PHST- 2002/02/01 00:00 [received] PHST- 2002/04/16 00:00 [accepted] PHST- 2002/08/30 10:00 [pubmed] PHST- 2002/09/27 06:00 [medline] PHST- 2002/08/30 10:00 [entrez] AID - 10.1038/sj.leu.2402615 [doi] PST - ppublish SO - Leukemia. 2002 Sep;16(9):1782-90. doi: 10.1038/sj.leu.2402615.